SCHEMBL3604547

SCHEMBL3604547

CCCN1CCc2cc(C(=O)O)ccc2C1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.49
KDM2B Q8NHM5 1/20 0.48
DRD3 P35462 6/20 0.48
DRD2 P14416 5/20 0.48
MAPT P10636 3/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
HTR1A P08908 4/20 0.46
HTR7 P34969 4/20 0.46
HTR2B P41595 4/20 0.46
HRH1 P35367 3/20 0.46
HTR2A P28223 3/20 0.46
SLC6A4 P31645 2/20 0.46
PNMT P11086 1/20 0.46
KMT2A Q03164 2/20 0.44
LMNA P02545 1/20 0.44
HTT P42858 1/20 0.44
GFER P55789 1/20 0.44
KDM4E B2RXH2 1/20 0.44
MEN1 O00255 1/20 0.44
HCAR3 P49019 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20178641 0.88 ALDH1A1 (0.51) ALDH1A1DRD3DRD2HTR1AHTR7
SCHEMBL3350732 0.86 DRD2 (0.59) ALDH1A1DRD3DRD2HTR1AHTR7
SCHEMBL4519212 0.83 HPGD (0.55) ALDH1A1KDM2BSMN1; SMN2LMNAHPGD
SCHEMBL7788367 0.82 ITGB3 (0.58) ALDH1A1DRD3DRD2HTR1AHTR7
SCHEMBL4563718 0.82 ALDH1A1 (0.57) ALDH1A1KDM2BDRD3DRD2MAPT
SCHEMBL4436447 0.81 NAMPT (0.53) ALDH1A1KMT2AKDM4EHPGDNAMPT
SCHEMBL3313430 0.80 ALDH1A1 (0.61) ALDH1A1DRD3DRD2SLC6A4
SCHEMBL30839551 0.80 ALDH1A1 (0.61) ALDH1A1DRD3DRD2SLC6A4
SCHEMBL27490478 0.80 ALDH1A1 (0.49) ALDH1A1MAPTSMN1; SMN2KMT2ALMNA
SCHEMBL27774602 0.80 ALDH1A1 (0.49) ALDH1A1DRD3DRD2SMN1; SMN2HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100041696-A1 Compounds SMITHKLINE BEECHAM CORPORATION 2010-02-18 US disclosed
EP-2144895-A2 ISOQUINOLINECARBOXAMIDES AS INHIBITORS OF STEAROYL-COA DESATURASE (SCD) SmithKline Beecham Corporation (US) 2010-01-20 EP disclosed
WO-2008074824-A2 ISOQUINOLINECARBOXAMIDES AS INHIBITORS OF STEAROYL-COA DESATURASE (SCD) SMITHKLINE BEECHAM CORPORATION (US) 2008-06-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100041696-A1 Compounds CYP11B2, SCD, CYP3A5 ALDH1A1 430/4885KDM2B 1489/4885DRD3 2020/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.